319 related articles for article (PubMed ID: 25883022)
21. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
22. Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.
Gewinner C; Wang ZC; Richardson A; Teruya-Feldstein J; Etemadmoghadam D; Bowtell D; Barretina J; Lin WM; Rameh L; Salmena L; Pandolfi PP; Cantley LC
Cancer Cell; 2009 Aug; 16(2):115-25. PubMed ID: 19647222
[TBL] [Abstract][Full Text] [Related]
23. Deletion of inositol polyphosphate 4-phosphatase type-II B affects spermatogenesis in mice.
Ceyhan Y; Zhang M; Guo J; Sandoval CG; Vacher J; Kaftanovskaya EM; Agoulnik AI; Agoulnik IU
PLoS One; 2020; 15(5):e0233163. PubMed ID: 32413098
[TBL] [Abstract][Full Text] [Related]
24. Phosphoinositide signaling in cancer: INPP4B Akt(s) out.
Woolley JF; Dzneladze I; Salmena L
Trends Mol Med; 2015 Sep; 21(9):530-2. PubMed ID: 26150301
[TBL] [Abstract][Full Text] [Related]
25. Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death.
Weng LP; Gimm O; Kum JB; Smith WM; Zhou XP; Wynford-Thomas D; Leone G; Eng C
Hum Mol Genet; 2001 Feb; 10(3):251-8. PubMed ID: 11159944
[TBL] [Abstract][Full Text] [Related]
26. Alterations of INPP4B, PIK3CA and pAkt of the PI3K pathway are associated with squamous cell carcinoma of the lung.
Stjernström A; Karlsson C; Fernandez OJ; Söderkvist P; Karlsson MG; Thunell LK
Cancer Med; 2014 Apr; 3(2):337-48. PubMed ID: 24500884
[TBL] [Abstract][Full Text] [Related]
27. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
Fang J; Ding M; Yang L; Liu LZ; Jiang BH
Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
[TBL] [Abstract][Full Text] [Related]
28. Inositol polyphosphate-4-phosphatase type II plays critical roles in the modulation of cadherin-mediated adhesion dynamics of pancreatic ductal adenocarcinomas.
Zhang B; Wang W; Li C; Liu R
Cell Adh Migr; 2018; 12(6):548-563. PubMed ID: 29952716
[TBL] [Abstract][Full Text] [Related]
29. High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase/akt pathway in thyroid tumors.
Wang Y; Hou P; Yu H; Wang W; Ji M; Zhao S; Yan S; Sun X; Liu D; Shi B; Zhu G; Condouris S; Xing M
J Clin Endocrinol Metab; 2007 Jun; 92(6):2387-90. PubMed ID: 17426084
[TBL] [Abstract][Full Text] [Related]
30. Inositol polyphosphate 4-phosphatase type II regulation of androgen receptor activity.
Zhang M; Suarez E; Vasquez JL; Nathanson L; Peterson LE; Rajapakshe K; Basil P; Weigel NL; Coarfa C; Agoulnik IU
Oncogene; 2019 Feb; 38(7):1121-1135. PubMed ID: 30228349
[TBL] [Abstract][Full Text] [Related]
31. INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas.
Chi MN; Guo ST; Wilmott JS; Guo XY; Yan XG; Wang CY; Liu XY; Jin L; Tseng HY; Liu T; Croft A; Hondermarck H; Scolyer RA; Jiang CC; Zhang XD
Oncotarget; 2015 Nov; 6(37):39891-907. PubMed ID: 26573229
[TBL] [Abstract][Full Text] [Related]
32. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
33. SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer.
Gasser JA; Inuzuka H; Lau AW; Wei W; Beroukhim R; Toker A
Mol Cell; 2014 Nov; 56(4):595-607. PubMed ID: 25458846
[TBL] [Abstract][Full Text] [Related]
34. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
[TBL] [Abstract][Full Text] [Related]
35. E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression.
Lau MT; Klausen C; Leung PC
Oncogene; 2011 Jun; 30(24):2753-66. PubMed ID: 21297666
[TBL] [Abstract][Full Text] [Related]
36. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
[TBL] [Abstract][Full Text] [Related]
37. The Inositol Polyphosphate 5-Phosphatase PIPP Regulates AKT1-Dependent Breast Cancer Growth and Metastasis.
Ooms LM; Binge LC; Davies EM; Rahman P; Conway JR; Gurung R; Ferguson DT; Papa A; Fedele CG; Vieusseux JL; Chai RC; Koentgen F; Price JT; Tiganis T; Timpson P; McLean CA; Mitchell CA
Cancer Cell; 2015 Aug; 28(2):155-69. PubMed ID: 26267533
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.
Furuya F; Lu C; Willingham MC; Cheng SY
Carcinogenesis; 2007 Dec; 28(12):2451-8. PubMed ID: 17660507
[TBL] [Abstract][Full Text] [Related]
39. MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2.
Nowak DG; Cho H; Herzka T; Watrud K; DeMarco DV; Wang VM; Senturk S; Fellmann C; Ding D; Beinortas T; Kleinman D; Chen M; Sordella R; Wilkinson JE; Castillo-Martin M; Cordon-Cardo C; Robinson BD; Trotman LC
Cancer Discov; 2015 Jun; 5(6):636-51. PubMed ID: 25829425
[TBL] [Abstract][Full Text] [Related]
40. INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancer.
Rodgers SJ; Ooms LM; Oorschot VMJ; Schittenhelm RB; Nguyen EV; Hamila SA; Rynkiewicz N; Gurung R; Eramo MJ; Sriratana A; Fedele CG; Caramia F; Loi S; Kerr G; Abud HE; Ramm G; Papa A; Ellisdon AM; Daly RJ; McLean CA; Mitchell CA
Nat Commun; 2021 May; 12(1):3140. PubMed ID: 34035258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
